13F-HR filed by Affinity Asset Advisors, LLC
Affinity Asset Advisors, LLC filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 71 holding rows worth $286,798,314.
- Accession
- 0001387131-23-009765
- Filer
- CIK 1773195
- Filed
- 2023-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2023
A holdings report, 71 entries on the cover page, a total value of $286,798,314 stated on the cover page (in dollars after the unit check, H1), rows summing to $286,798,314 with VALUE read as dollars as filed, 13F file number 028-20754. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 92,500 | $21,367,500 | dollars as filed | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 550,000 | $17,484,500 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 211,608 | $14,518,425 | dollars as filed | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 321,017 | $12,333,473 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 53,100 | $12,266,100 | dollars as filed | call |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 1,600,000 | $12,048,000 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 201,887 | $11,574,182 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,050,118 | $11,498,792 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 40,000 | $11,394,000 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 910,317 | $9,631,154 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 447,667 | $9,463,680 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806XAB8 | NOTE 2.500% 3/1 | 12,000,000 | $9,452,614 | dollars as filed | principal |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 226,275 | $7,154,816 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 100,000 | $6,828,000 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 376,000 | $6,467,200 | dollars as filed | put |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 350,000 | $5,673,500 | dollars as filed | put |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 900,723 | $5,575,475 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 650,875 | $5,421,789 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 57,760 | $5,155,080 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 260,000 | $4,932,200 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 300,000 | $4,863,000 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 60,000 | $4,294,200 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 751,796 | $4,187,504 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 125,148 | $4,082,328 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 1,589,017 | $3,781,860 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 300,000 | $3,462,000 | dollars as filed | |
| Esperion Therapeutics Inc | 29664WAB1 | NOTE 4.000%11/15/25 | 6,925,000 | $3,441,033 | dollars as filed | principal |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 130,000 | $3,408,600 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 100,696 | $3,302,829 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 130,400 | $3,102,216 | dollars as filed | call |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 29,105 | $2,967,546 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 87,031 | $2,952,962 | dollars as filed | |
| FIBROGEN INC | 31572Q808 | COM | 983,300 | $2,654,910 | dollars as filed | |
| FIBROGEN INC | 31572Q808 | COM | 983,300 | $2,654,910 | dollars as filed | put |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 60,376 | $2,324,476 | dollars as filed | |
| THESEUS PHARMACEUTICALS INC | 88369M101 | COM | 240,244 | $2,241,477 | dollars as filed | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 4,900,000 | $2,207,450 | dollars as filed | |
| VINCERX PHARMA INC | 92731L106 | COM NEW | 1,492,771 | $1,940,602 | dollars as filed | |
| LIANBIO ADR | 53000N108 | COM | 800,676 | $1,825,541 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 125,000 | $1,613,750 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 178,292 | $1,604,628 | dollars as filed | |
| PRECIGEN INC | 46122TAA0 | NOTE 3.500% 7/0 | 1,500,000 | $1,507,426 | dollars as filed | principal |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 600,000 | $1,290,000 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 187,675 | $1,283,697 | dollars as filed | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 150,000 | $1,258,500 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 118,891 | $1,222,199 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 100,000 | $1,189,000 | dollars as filed | |
| Aravive Inc | 03890D108 | Common / Ordinary Stock | 861,200 | $1,085,112 | dollars as filed | put |
| Inflarx Nv | N44821101 | COM | 240,200 | $1,071,292 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 62,500 | $1,065,625 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 100,000 | $999,000 | dollars as filed | |
| BIOATLA INC | 09077B104 | COM | 325,000 | $975,000 | dollars as filed | |
| FIBROGEN INC | 31572Q808 | COM | 340,000 | $918,000 | dollars as filed | call |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 10,000 | $911,000 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 12,500 | $898,250 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 300,068 | $855,194 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 30,000 | $776,100 | dollars as filed | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 202,349 | $714,292 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 13,923 | $695,315 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871103 | COM | 476,948 | $653,419 | dollars as filed | |
| IMMATICS N.V | N44445117 | *W EXP 07/01/202 | 187,204 | $632,750 | dollars as filed | |
| TALARIS THERAPEUTICS INC | 87410C104 | COM | 200,000 | $608,000 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 35,133 | $604,288 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 20,000 | $490,600 | dollars as filed | |
| SPY | 78462F103 | SHS | 18,087 | $488,256 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 250,000 | $450,000 | dollars as filed | |
| NLS PHARMACEUTICS LTD COM NEW | H57830103 | Stock | 400,000 | $440,000 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 267,574 | $428,118 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | WTS | 37,000 | $77,330 | dollars as filed | |
| Aravive Inc | 03890D108 | Common / Ordinary Stock | 33,600 | $42,336 | dollars as filed | call |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 75,000 | $13,913 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001387131-23-009765 | this filing | 2023-08-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001387131-23-010013 | base | 2023-08-21 | acceptance time not in the bulk data set |